{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Episurf Medical AB", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:06Z", "company": "Episurf Medical AB", "title": "Rättelse: Saknad MAR-etikett i tidigare pressmeddelande - Delårsrapport 1 januari - 31 mars 2026", "category": "Interimsrapport", "date": "2026-05-25", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b0fd2aeec5fb7a9565febc2bcf1d51c52&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "05256593.pdf", "url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8", "final_url": "https://attachment.news.eu.nasdaq.com/aab8a43e74fee5eace7bce8c45a8620f8", "filename": "05256593.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\05256593.pdf", "content_type": "application/pdf", "size": 979576, "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\05256593.pdf", "filename": "05256593.pdf", "extension": ".pdf", "size": 979576, "sha256": "5d82cf9d28de6d24fe2cafdcf299b47e6f69cf52c5ded7e4ce7ab0083547a295", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\05256593\\05256593.txt", "text_chars": 33267, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\05256593\\05256593.extraction.json" } } ], "announcement_id": "1443998", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:15Z", "company": "Episurf Medical AB", "title": "Episurf Medical AB publicerar årsredovisning för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-20", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b8f2373a3f89a4541b72925e8667191c5&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "03207922.pdf", "url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e", "final_url": "https://attachment.news.eu.nasdaq.com/a81b93c940a2b2561fb907e5d4868092e", "filename": "03207922.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\03207922.pdf", "content_type": "application/pdf", "size": 4423071, "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\03207922.pdf", "filename": "03207922.pdf", "extension": ".pdf", "size": 4423071, "sha256": "98f52adea34923f38cbece510aa866da6c82126f0c580e5291cbb9abdb60f0f5", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03207922\\03207922.txt", "text_chars": 284791, "metadata": { "page_count": 97, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03207922\\03207922.extraction.json" } } ], "announcement_id": "1427895", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:24Z", "company": "Episurf Medical AB", "title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2025", "category": "Bokslutskommuniké", "date": "2026-02-06", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bebe861794b68c63db7648158939fc184&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "02045726.pdf", "url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24", "final_url": "https://attachment.news.eu.nasdaq.com/a1bb32b8b6f7e30d498619f54e258bf24", "filename": "02045726.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\02045726.pdf", "content_type": "application/pdf", "size": 1904939, "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\02045726.pdf", "filename": "02045726.pdf", "extension": ".pdf", "size": 1904939, "sha256": "c388d1c855910f4f5c9ba52e62b0685e49760c8f452685d125a74a427e4870b5", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02045726\\02045726.txt", "text_chars": 43151, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02045726\\02045726.extraction.json" } } ], "announcement_id": "1418465", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:34Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 30 september 2025", "category": "Interimsrapport", "date": "2025-10-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b19340b196898e8d63427c8bfb089dcf3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "10238921.pdf", "url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0", "final_url": "https://attachment.news.eu.nasdaq.com/a60352723909d02bdb354d97cd07a8fe0", "filename": "10238921.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\10238921.pdf", "content_type": "application/pdf", "size": 2023170, "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\10238921.pdf", "filename": "10238921.pdf", "extension": ".pdf", "size": 2023170, "sha256": "9b9ee7842ea7c3f79acd844498db660d1369325111fd9f9fc529dacb619a69bc", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10238921\\10238921.txt", "text_chars": 46826, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10238921\\10238921.extraction.json" } } ], "announcement_id": "1396522", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:43Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 30 juni 2025", "category": "Interimsrapport", "date": "2025-07-11", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3b6c3039e428f6bf2dffdea6c6e81996&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "07108252.pdf", "url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11", "final_url": "https://attachment.news.eu.nasdaq.com/a97b92923ca6221d0b7b355374cdf8c11", "filename": "07108252.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\07108252.pdf", "content_type": "application/pdf", "size": 1851282, "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\07108252.pdf", "filename": "07108252.pdf", "extension": ".pdf", "size": 1851282, "sha256": "fed67fa327fcc0fe2a3c219c8466c92a00c08a61a455f69b30fe40078b228b88", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07108252\\07108252.txt", "text_chars": 42301, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07108252\\07108252.extraction.json" } } ], "announcement_id": "1377478", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:17:50Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 31 mars 2025", "category": "Interimsrapport", "date": "2025-04-10", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd069cb94f0918990aafbc4c3995f1bf4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "04095665.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3", "final_url": "https://attachment.news.eu.nasdaq.com/aa09ea965d322c5501bb7401ee50c54b3", "filename": "04095665.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\04095665.pdf", "content_type": "application/pdf", "size": 1864308, "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\04095665.pdf", "filename": "04095665.pdf", "extension": ".pdf", "size": 1864308, "sha256": "1c826e86f766fb0916829100e81db6fc31b0edf779f85409a6d3e5c00a2bafd8", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04095665\\04095665.txt", "text_chars": 39392, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04095665\\04095665.extraction.json" } } ], "announcement_id": "1355078", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:00Z", "company": "Episurf Medical AB", "title": "Episurf Medical AB publicerar årsredovisning för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-03-06", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b48348410fe68557d1c9726cf5a4e2ba1&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "03067038.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e", "final_url": "https://attachment.news.eu.nasdaq.com/a8a25e81acbd157814da20927ed5b497e", "filename": "03067038.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\03067038.pdf", "content_type": "application/pdf", "size": 3874636, "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\03067038.pdf", "filename": "03067038.pdf", "extension": ".pdf", "size": 3874636, "sha256": "0d541124ef181df99beb4ec4704da40d9ab287a48f1aeb6b3a6a71caa17206f3", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03067038\\03067038.txt", "text_chars": 284435, "metadata": { "page_count": 98, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03067038\\03067038.extraction.json" } } ], "announcement_id": "1347436", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:07Z", "company": "Episurf Medical AB", "title": "Bokslutskommuniké 1 januari - 31 december 2024", "category": "Bokslutskommuniké", "date": "2025-02-05", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd66d560eb0ef55b36c7c36ebbb7ce8d7&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "02042157.pdf", "url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606", "final_url": "https://attachment.news.eu.nasdaq.com/a1f3af771049d2ccfe7dbfab35a891606", "filename": "02042157.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\02042157.pdf", "content_type": "application/pdf", "size": 1942776, "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\02042157.pdf", "filename": "02042157.pdf", "extension": ".pdf", "size": 1942776, "sha256": "b5a11beb27fe3efde2a47b3fdd804df75dd2ca4c18fcb40c20d135ddda461477", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\02042157\\02042157.txt", "text_chars": 41954, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\02042157\\02042157.extraction.json" } } ], "announcement_id": "1340876", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:15Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 30 september 2024", "category": "Interimsrapport", "date": "2024-10-25", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb9902a842c2af51a0454de22f10b76bb&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "10247432.pdf", "url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba", "final_url": "https://attachment.news.eu.nasdaq.com/a06d68daf7ae64e385c246f482cc074ba", "filename": "10247432.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\10247432.pdf", "content_type": "application/pdf", "size": 1975556, "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\10247432.pdf", "filename": "10247432.pdf", "extension": ".pdf", "size": 1975556, "sha256": "14fa98a3ab928429690d7871bcf1ae6652f53ccf1e527d17b84206f2ee01c4e6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10247432\\10247432.txt", "text_chars": 44738, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10247432\\10247432.extraction.json" } } ], "announcement_id": "1323648", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:23Z", "company": "Episurf Medical AB", "title": "DELÅRSRAPPORT 1 JANUARI - 30 JUNI 2024", "category": "Halvårsrapport", "date": "2024-07-12", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b80e29f315ac67e940e6ff2dc5dd86a8c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "07114860.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7", "final_url": "https://attachment.news.eu.nasdaq.com/a6a2d11acb4897d1de569de15eec47bc7", "filename": "07114860.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\07114860.pdf", "content_type": "application/pdf", "size": 2037109, "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\07114860.pdf", "filename": "07114860.pdf", "extension": ".pdf", "size": 2037109, "sha256": "83eca184a4597906e0794eab275f815da5c0193c770926d1c29368dbf1df2c9a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07114860\\07114860.txt", "text_chars": 41780, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07114860\\07114860.extraction.json" } } ], "announcement_id": "1306210", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:31Z", "company": "Episurf Medical AB", "title": "DELÅRSRAPPORT 1 JANUARI - 31 MARS 2024", "category": "Interimsrapport", "date": "2024-04-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1f224de67bca57f2c21c24cd6eaf520c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "04236511.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad", "final_url": "https://attachment.news.eu.nasdaq.com/a7a36e40e82ac82dc2446c736bd9321ad", "filename": "04236511.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\04236511.pdf", "content_type": "application/pdf", "size": 2245240, "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\04236511.pdf", "filename": "04236511.pdf", "extension": ".pdf", "size": 2245240, "sha256": "b13ec861cf9e4818e4f9fb1e699988603eb9495627c5f2fb55f7860c1d7d8e28", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04236511\\04236511.txt", "text_chars": 39221, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04236511\\04236511.extraction.json" } } ], "announcement_id": "1290047", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:40Z", "company": "Episurf Medical AB", "title": "Episurf Medical AB publicerar årsredovisning för 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-03-07", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7c8de5b94e440ab09004ffa3516c8523&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "03072581.pdf", "url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a", "final_url": "https://attachment.news.eu.nasdaq.com/acbe979e0c81f89598f27cd4285c03d4a", "filename": "03072581.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\03072581.pdf", "content_type": "application/pdf", "size": 3514931, "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\03072581.pdf", "filename": "03072581.pdf", "extension": ".pdf", "size": 3514931, "sha256": "139cf444afd331abccb74ba0d1f7a563ede9bc0029ddeea094e71af4e3e709a6", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03072581\\03072581.txt", "text_chars": 288926, "metadata": { "page_count": 97, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03072581\\03072581.extraction.json" } } ], "announcement_id": "1279913", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:48Z", "company": "Episurf Medical AB", "title": "BOKSLUTSKOMMUNIKÉ 1 JANUARI - 31 DECEMBER 2023", "category": "Bokslutskommuniké", "date": "2024-02-09", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdf35a0d9eb0277f6313daf14902dcb03&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02085164.pdf", "url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465", "final_url": "https://attachment.news.eu.nasdaq.com/a52f36b84a728bf9f93a768652b782465", "filename": "02085164.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\02085164.pdf", "content_type": "application/pdf", "size": 2314601, "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\02085164.pdf", "filename": "02085164.pdf", "extension": ".pdf", "size": 2314601, "sha256": "963175a0cae339404ee7f5d50c015bf3c357bee6ec60876c6ca4685c52b3a9f5", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02085164\\02085164.txt", "text_chars": 40883, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02085164\\02085164.extraction.json" } } ], "announcement_id": "1273867", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:18:57Z", "company": "Episurf Medical AB", "title": "DELÅRSRAPPORT 1 JANUARI - 30 SEPTEMBER 2023", "category": "Interimsrapport", "date": "2023-10-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b127be84e3c9301d02221e9551be65e28&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "10263062.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132", "final_url": "https://attachment.news.eu.nasdaq.com/a8ba90b376b7b000a0c7f7c1cea1bf132", "filename": "10263062.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\10263062.pdf", "content_type": "application/pdf", "size": 2300818, "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\10263062.pdf", "filename": "10263062.pdf", "extension": ".pdf", "size": 2300818, "sha256": "159810e20f79e6b8554fc810a4e64c7d5a6b12e079ee0cacc088142454df6ec1", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10263062\\10263062.txt", "text_chars": 43445, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10263062\\10263062.extraction.json" } } ], "announcement_id": "1255488", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:19:05Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 30 juni 2023", "category": "Halvårsrapport", "date": "2023-07-14", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb0fb3d67258eaddb2e7546c8a2a03740&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "07133448.pdf", "url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7", "final_url": "https://attachment.news.eu.nasdaq.com/a1e9d925eb1bcdc5f8940c8c70a486cb7", "filename": "07133448.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\07133448.pdf", "content_type": "application/pdf", "size": 2195453, "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\07133448.pdf", "filename": "07133448.pdf", "extension": ".pdf", "size": 2195453, "sha256": "214d155efff34ae01856d9c3f35cef58fd458df12920d8c0a5273e6d334acf8b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07133448\\07133448.txt", "text_chars": 43490, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07133448\\07133448.extraction.json" } } ], "announcement_id": "1238411", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T03:19:13Z", "company": "Episurf Medical AB", "title": "Delårsrapport 1 januari - 31 mars 2023", "category": "Interimsrapport", "date": "2023-04-28", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3653d4b260e2aba8f768d542b131dfa3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "04278325.pdf", "url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb", "final_url": "https://attachment.news.eu.nasdaq.com/aa27343098804155dab684a735ac775fb", "filename": "04278325.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\04278325.pdf", "content_type": "application/pdf", "size": 2127316, "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\04278325.pdf", "filename": "04278325.pdf", "extension": ".pdf", "size": 2127316, "sha256": "769a8e31fad3c087af20f15ca96f98cfcad5714bbae2ae3146c16b6af816131e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04278325\\04278325.txt", "text_chars": 38866, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\episurf-medical-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04278325\\04278325.extraction.json" } } ], "announcement_id": "1223716", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "2b04e261958ef0d6efee724e8ed09fcf1783b9a388bae5c04bbb76ea13519959" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7e4477e4d1905f689ce81dcb96d02c72fffe31dcb38ca2309b89b2b49e00482d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "9122cbffb97224739b9869671fc2c7accfe2c5f923d93809d463b5769dac5a79" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a39b9e86de35097781430ba35024d1cbc0fb87a711b28c1518d2023425e58114" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cb19da1f8ff797bad1bfd42c7a262d5887ca7934981c2ee8f1d24a97dd6be12a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 86, "new_rows": 86, "total_count": null, "from_cache": false, "body_sha256": "c5ba3bffad5007084bab3af1921a4f296ba72c6ece4ba3cb5f67ec72832c867f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 6, "new_rows": 6, "total_count": null, "from_cache": false, "body_sha256": "bce80f2849a7ddc3dc068d4f1baab0ada961dc3e6c9cca4e435de59d3ecbe82e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=6&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 6, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bd9c05e04ff6560502e6bf3875897cb7834465fc4920a52158db62f481ce3d43" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8afd0d69a965ac6a187775545dc44318f51323e2dd1233f382ada1a7a4af8718" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d3049db2b69531fa27ed15e743d861c718cd058dcd422eef1e754148f14de047" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "cf0f80400ce350dbfa9dbe3be4d6f447c05e9525f9bcabf20744d1ba34752edc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "c3fb6f1a16e90a90ee62934baa2436aced7128da5994fad9ecf1b28d71a88e54" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 23, "new_rows": 23, "total_count": null, "from_cache": false, "body_sha256": "ff8181bf61902f0a3cc761660dbc7c2e4c94330d90221045f27c94581abb2b26" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=423&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 423, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "68b11d0cf8a731f9b22ac6941a6e6af8a7c665337f9ccf75251351f5f34e2528" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 1, "new_rows": 1, "total_count": null, "from_cache": false, "body_sha256": "d83905040c624fd085ab18ae670751777edb7240fa15dd3c1653d1fea98a0336" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Episurf+Medical&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=1&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 1, "pagination": "row-offset", "query_text": "Episurf Medical", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b0baeec2e2e08d034f3e6378faf59c9d544cb3d1cd4e64d2dae5360d27808f71" } ], "identity": { "slug": "", "instrument_id": "TX712898", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/epis-b?id=TX712898" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Episurf Medical", "retrieved_at": "2026-08-07T03:19:13Z" }